Stephanie Sasse

3.5k total citations
48 papers, 1.6k citations indexed

About

Stephanie Sasse is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephanie Sasse has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephanie Sasse's work include Lymphoma Diagnosis and Treatment (38 papers), Lung Cancer Treatments and Mutations (18 papers) and Viral-associated cancers and disorders (8 papers). Stephanie Sasse is often cited by papers focused on Lymphoma Diagnosis and Treatment (38 papers), Lung Cancer Treatments and Mutations (18 papers) and Viral-associated cancers and disorders (8 papers). Stephanie Sasse collaborates with scholars based in Germany, United States and Austria. Stephanie Sasse's co-authors include Andreas Engert, Peter Borchmann, Achim Rothe, Bastian von Tresckow, Paul J. Bröckelmann, Dennis A. Eichenauer, Boris Böll, Elke Pogge von Strandmann, Katrin S. Reiners and Michael Fuchs and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Stephanie Sasse

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Sasse Germany	23	819	753	624	299	258	48	1.6k
Roland Schnell Germany	17	500 0.6×	662 0.9×	506 0.8×	297 1.0×	161 0.6×	30	1.2k
Wolfram Jung Germany	17	821 1.0×	823 1.1×	489 0.8×	401 1.3×	104 0.4×	41	1.7k
Tatyana Feldman United States	23	1.3k 1.6×	1.5k 2.0×	463 0.7×	185 0.6×	450 1.7×	159	2.0k
Andy I. Chen United States	14	797 1.0×	829 1.1×	552 0.9×	127 0.4×	284 1.1×	38	1.5k
Martine E.D. Chamuleau Netherlands	21	713 0.9×	586 0.8×	660 1.1×	275 0.9×	97 0.4×	103	1.6k
Carsten Zwick Germany	15	525 0.6×	616 0.8×	494 0.8×	184 0.6×	266 1.0×	32	1.3k
Dirk Huebner United States	15	1.1k 1.4×	1.4k 1.8×	261 0.4×	159 0.5×	499 1.9×	44	1.8k
Jocelyn Maragulia United States	16	581 0.7×	993 1.3×	287 0.5×	112 0.4×	465 1.8×	37	1.3k
Amitkumar Mehta United States	20	834 1.0×	515 0.7×	349 0.6×	116 0.4×	76 0.3×	114	1.3k
Sascha Ansén Germany	17	521 0.6×	339 0.5×	482 0.8×	253 0.8×	95 0.4×	25	1.2k

Countries citing papers authored by Stephanie Sasse

Since Specialization

Citations

This map shows the geographic impact of Stephanie Sasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Sasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Sasse more than expected).

Fields of papers citing papers by Stephanie Sasse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Sasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Sasse. The network helps show where Stephanie Sasse may publish in the future.

Co-authorship network of co-authors of Stephanie Sasse

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Sasse. A scholar is included among the top collaborators of Stephanie Sasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Sasse. Stephanie Sasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García-Márquez, María A., Martin Thelen, Sarah Reinke, et al.. (2021). Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. Leukemia. 36(3). 760–771. 19 indexed citations

Sasse, Stephanie, Annette Plütschow, Andreas Hüttmann, et al.. (2020). AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma: Final Results of an Open-Label, Randomized, Multicenter Phase II Trial. Blood. 136(Supplement 1). 31–32. 8 indexed citations

Sasse, Stephanie, et al.. (2020). Checkpoint-Inhibitoren bei Hodgkin-Lymphom. Der Internist. 61(7). 660–668. 1 indexed citations

Bröckelmann, Paul J., Stephanie Sasse, & Andreas Engert. (2018). Balancing risk and benefit in early-stage classical Hodgkin lymphoma. Blood. 131(15). 1666–1678. 29 indexed citations

Tresckow, Bastian von, Stefanie Kreissl, Helen Goergen, et al.. (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. The Lancet Haematology. 5(10). e462–e473. 32 indexed citations

Sasse, Stephanie, et al.. (2016). The emerging role of immune checkpoint inhibition in malignant lymphoma. Haematologica. 102(1). 30–42. 82 indexed citations

Sasse, Stephanie, Horst Müller, Lenka Šmardová, et al.. (2015). Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group. Leukemia & lymphoma. 57(5). 1067–1073. 9 indexed citations

Zinzani, Pier Luigi, Stephanie Sasse, John Radford, Oluwatoyin Shonukan, & Vijayveer Bonthapally. (2015). Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature. Critical Reviews in Oncology/Hematology. 95(3). 359–369. 24 indexed citations

Rothe, Achim, Stephanie Sasse, Max S. Topp, et al.. (2014). Specific NK Cell Activation to Treat Relapsed/Refractory (r/r) Hodgkin Lymphoma (HL) Patients – Final, Updated Data on Clinical Outcome, Pharmacokinetics and Pharmacodynamics of a Phase 1 Study Investigating AFM13, a Bispecific Anti-CD30/CD16A Tandab. Blood. 124(21). 1753–1753. 1 indexed citations

10.

Kahraman, Deniz, Sebastian Theurich, Achim Rothe, et al.. (2013). 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma. Leukemia & lymphoma. 55(4). 811–816. 17 indexed citations

11.

Böll, Boris, Helen Goergen, Julia Meißner, et al.. (2013). Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group. Journal of Clinical Oncology. 31(35). 4431–4437. 35 indexed citations

12.

Rothe, Achim, Stephanie Sasse, Helen Goergen, et al.. (2012). Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience. Blood. 120(7). 1470–1472. 60 indexed citations

13.

Sasse, Stephanie, Beate Klimm, Helen Görgen, et al.. (2012). Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Annals of Oncology. 23(11). 2953–2959. 25 indexed citations

14.

Rothe, Achim, Stephanie Sasse, Helen Goergen, et al.. (2012). Brentuximab Vedotin (SGN-35) in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies without Prior High-Dose Chemotherapy and Stem Cell Transplantation.. Blood. 120(21). 2743–2743. 6 indexed citations

15.

Sasse, Stephanie, Horst Mueller, Lenka Šmardová, et al.. (2012). Prognostic Relevance of Dose-Density of DHAP-Reinduction Therapy in Relapsed HL: An Analysis of the German Hodgkin-Study Group (GHSG). Blood. 120(21). 552–552. 3 indexed citations

16.

Strandmann, Elke Pogge von, Venkateswara R. Simhadri, Bastian von Tresckow, et al.. (2007). Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells. Immunity. 27(6). 965–974. 271 indexed citations

17.

Tresckow, Bastian von, Elke Pogge von Strandmann, Stephanie Sasse, et al.. (2007). Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivo. Haematologica. 92(5). 682–685. 16 indexed citations

18.

Rothe, Achim, Alexander Klimka, Mehmet Kemal Tur, et al.. (2004). Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines.. International Journal of Molecular Medicine. 14(4). 729–35. 20 indexed citations

19.

Pfister, K., Bianca M. Wittig, K. W. Ecker, et al.. (2001). The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice. International Journal of Colorectal Disease. 17(2). 77–84. 4 indexed citations

20.

Tur, Mehmet Kemal, Stephanie Sasse, Michael Stöcker, et al.. (2001). An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines. International Journal of Molecular Medicine. 8(5). 579–84. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact